Viral loads, histology, and adverse events in transgenic mice after passive transfer of serum from black-footed ferrets (Mustela nigripes) used to assess the anti-viral efficacy of a subunit SARS-CoV-2 vaccine candidate
October 11, 2022
This data set provides biological information from of a captive study of transgenic mice that received either passive serum transfers from black-footed ferrets (BFFs) that were vaccinated against SARS-CoV-2 or BFFs that were unvaccinated, or a monoclonal antibody against SARS-CoV-2 or lastly a placebo. After these treatments mice were challenged with SARS-CoV-2. The data included here have viral loads in the lungs of treated mice, as well as histological results from various tissues collected at the end of the study.
Citation Information
Publication Year | 2022 |
---|---|
Title | Viral loads, histology, and adverse events in transgenic mice after passive transfer of serum from black-footed ferrets (Mustela nigripes) used to assess the anti-viral efficacy of a subunit SARS-CoV-2 vaccine candidate |
DOI | 10.5066/P9GZEXN9 |
Authors | Ariel E Leon, Della Garelle, Airn Hartwig, Elizabeth A Falendysz, Hon S Ip, Julia S Lankton, Tyler N Tretten, Terry Spraker, Richard Bowen, Tonie E Rocke |
Product Type | Data Release |
Record Source | USGS Asset Identifier Service (AIS) |
USGS Organization | National Wildlife Health Center |
Rights | This work is marked with CC0 1.0 Universal |
Related
Immunogenicity, safety, and anti-viral efficacy of a subunit SARS-CoV-2 vaccine candidate in captive black-footed ferrets (Mustela nigripes) and their susceptibility to viral challenge
A preliminary vaccination trial against the emergent pathogen, SARS-CoV-2, was completed in captive black-footed ferrets (Mustela nigripes; BFF) to assess safety, immunogenicity, and anti-viral efficacy. Vaccination and boosting of 15 BFF with purified SARS-CoV-2 S1 subunit protein produced a nearly 150-fold increase in mean antibody titers compared to pre-vaccination titers. Serum antibody respon
Authors
Ariel Elizabeth Leon, Della Garelle, Airn Hartwig, Elizabeth Falendysz, Hon S. Ip, Julia S. Lankton, Tyler Tretten, Terry Spraker, Richard Bowen, Tonie E. Rocke
Related
Immunogenicity, safety, and anti-viral efficacy of a subunit SARS-CoV-2 vaccine candidate in captive black-footed ferrets (Mustela nigripes) and their susceptibility to viral challenge
A preliminary vaccination trial against the emergent pathogen, SARS-CoV-2, was completed in captive black-footed ferrets (Mustela nigripes; BFF) to assess safety, immunogenicity, and anti-viral efficacy. Vaccination and boosting of 15 BFF with purified SARS-CoV-2 S1 subunit protein produced a nearly 150-fold increase in mean antibody titers compared to pre-vaccination titers. Serum antibody respon
Authors
Ariel Elizabeth Leon, Della Garelle, Airn Hartwig, Elizabeth Falendysz, Hon S. Ip, Julia S. Lankton, Tyler Tretten, Terry Spraker, Richard Bowen, Tonie E. Rocke